Covid-19 Impact on Cancer Diagnostics Market, Global Research Reports 2020-2021

Publisher Name :
Date: 19-May-2020
No. of pages: 93
Inquire Before Buying

This report covers market size and forecasts of Cancer Diagnostics, including the following market information:

- Global Cancer Diagnostics Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million)

- Global Cancer Diagnostics Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million)

- Global Cancer Diagnostics Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million)

- Global Cancer Diagnostics Market Size by Company, 2019- 2020 (quarterly data), (US$ Million)

Key market players

Major competitors identified in this market include Becton, Dickinson and Company, GE Healthcare, Abbott, Roche, Thermo Fisher Scientific, Agilent Technologies, Illumina, Siemens Healthcare, C.R. Bard, etc.

Based on the Region:

- Asia-Pacific (China, Japan, South Korea, India and ASEAN)

- North America (US and Canada)

- Europe (Germany, France, UK and Italy)

- Rest of World (Latin America, Middle East & Africa)

Based on the Type:

- Platform-based

- Instrument-based

Based on the Application:

- Breast Cancer

- Lung Cancer

- Colorectal Cancer

- Melanoma

- Others

Covid-19 Impact on Cancer Diagnostics Market, Global Research Reports 2020-2021

Table of Contents
1.1 Research Scope
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Cancer Diagnostics Industry
1.7 COVID-19 Impact: Cancer Diagnostics Market Trends
2 Global Cancer Diagnostics Quarterly Market Size Analysis
2.1 Cancer Diagnostics Business Impact Assessment - COVID-19
2.1.1 Global Cancer Diagnostics Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Cancer Diagnostics Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 Quarterly Competitive Assessment, 2020
3.1 By Players, Global Cancer Diagnostics Quarterly Market Size, 2019 VS 2020
3.2 By Players, Cancer Diagnostics Headquarters and Area Served
3.3 Date of Key Players Enter into Cancer Diagnostics Market
3.4 Key Players Cancer Diagnostics Product Offered
3.5 Mergers & Acquisitions, Expansion Plans
4 Impact of Covid-19 on Cancer Diagnostics Segments, By Type
4.1 Introduction
1.4.1 Platform-based
1.4.2 Instrument-based
4.2 By Type, Global Cancer Diagnostics Market Size, 2019-2021
5 Impact of Covid-19 on Cancer Diagnostics Segments, By Application
5.1 Overview
5.5.1 Breast Cancer
5.5.2 Lung Cancer
5.5.3 Colorectal Cancer
5.5.4 Melanoma
5.5.5 Others
5.2 By Application, Global Cancer Diagnostics Market Size, 2019-2021
5.2.1 By Application, Global Cancer Diagnostics Market Size by Application, 2019-2021
6 Geographic Analysis
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 Company Profiles
7.1 Becton, Dickinson and Company
7.1.1 Becton, Dickinson and Company Business Overview
7.1.2 Becton, Dickinson and Company Cancer Diagnostics Quarterly Revenue, 2020
7.1.3 Becton, Dickinson and Company Cancer Diagnostics Product Introduction
7.1.4 Becton, Dickinson and Company Response to COVID-19 and Related Developments
7.2 GE Healthcare
7.2.1 GE Healthcare Business Overview
7.2.2 GE Healthcare Cancer Diagnostics Quarterly Revenue, 2020
7.2.3 GE Healthcare Cancer Diagnostics Product Introduction
7.2.4 GE Healthcare Response to COVID-19 and Related Developments
7.3 Abbott
7.3.1 Abbott Business Overview
7.3.2 Abbott Cancer Diagnostics Quarterly Revenue, 2020
7.3.3 Abbott Cancer Diagnostics Product Introduction
7.3.4 Abbott Response to COVID-19 and Related Developments
7.4 Roche
7.4.1 Roche Business Overview
7.4.2 Roche Cancer Diagnostics Quarterly Revenue, 2020
7.4.3 Roche Cancer Diagnostics Product Introduction
7.4.4 Roche Response to COVID-19 and Related Developments
7.5 Thermo Fisher Scientific
7.5.1 Thermo Fisher Scientific Business Overview
7.5.2 Thermo Fisher Scientific Cancer Diagnostics Quarterly Revenue, 2020
7.5.3 Thermo Fisher Scientific Cancer Diagnostics Product Introduction
7.5.4 Thermo Fisher Scientific Response to COVID-19 and Related Developments
7.6 Agilent Technologies
7.6.1 Agilent Technologies Business Overview
7.6.2 Agilent Technologies Cancer Diagnostics Quarterly Revenue, 2020
7.6.3 Agilent Technologies Cancer Diagnostics Product Introduction
7.6.4 Agilent Technologies Response to COVID-19 and Related Developments
7.7 Illumina
7.7.1 Illumina Business Overview
7.7.2 Illumina Cancer Diagnostics Quarterly Revenue, 2020
7.7.3 Illumina Cancer Diagnostics Product Introduction
7.7.4 Illumina Response to COVID-19 and Related Developments
7.8 Siemens Healthcare
7.8.1 Siemens Healthcare Business Overview
7.8.2 Siemens Healthcare Cancer Diagnostics Quarterly Revenue, 2020
7.8.3 Siemens Healthcare Cancer Diagnostics Product Introduction
7.8.4 Siemens Healthcare Response to COVID-19 and Related Developments
7.9 C.R. Bard
7.9.1 C.R. Bard Business Overview
7.9.2 C.R. Bard Cancer Diagnostics Quarterly Revenue, 2020
7.9.3 C.R. Bard Cancer Diagnostics Product Introduction
7.9.4 C.R. Bard Response to COVID-19 and Related Developments
8 Key Findings
9 Appendix
9.1 About US
9.2 Disclaimer
List of Tables

Table 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Cancer Diagnostics Assessment
Table 9. COVID-19 Impact: Cancer Diagnostics Market Trends
Table 10. COVID-19 Impact Global Cancer Diagnostics Market Size
Table 11. Global Cancer Diagnostics Quarterly Market Size, 2020 (US$ Million)
Table 12. Global Cancer Diagnostics Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 13. Global Cancer Diagnostics Market Growth Drivers
Table 14. Global Cancer Diagnostics Market Restraints
Table 15. Global Cancer Diagnostics Market Opportunities
Table 16. Global Cancer Diagnostics Market Challenges
Table 17. By Players, Cancer Diagnostics Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 18. Key Players, Cancer Diagnostics Revenue Market Share, 2019 VS 2020 (%)
Table 19. Key Cancer Diagnostics Players Headquarters and Area Served
Table 20. Date of Key Players Enter into Cancer Diagnostics Market
Table 21. Key Players Cancer Diagnostics Product Type
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. By Players, Global Cancer Diagnostics Market Size 2019-2021, (US$ Million)
Table 24. Global Cancer Diagnostics Market Size by Application: 2019-2021 (US$ Million)
Table 25. Global Cancer Diagnostics Market Size by Region, 2019-2021 (US$ Million)
Table 26. By Country, North America Cancer Diagnostics Market Size, 2019-2021 (US$ Million)
Table 27. By Type, US Cancer Diagnostics Market Size, 2019-2021 (US$ Million)
Table 28. By Application, US Cancer Diagnostics Market Size, 2019-2021 (US$ Million)
Table 29. By Type, Canada Cancer Diagnostics Market Size, 2019-2021 (US$ Million)
Table 30. By Application, Canada Cancer Diagnostics Market Size, 2019-2021 (US$ Million)
Table 31. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 32. By Country, Europe Cancer Diagnostics Market Size, 2019-2021 (US$ Million)
Table 33. By Type, Germany Cancer Diagnostics Market Size, 2019-2021 (US$ Million)
Table 34. By Application, Germany Cancer Diagnostics Market Size, 2019-2021 (US$ Million)
Table 35. By Type, France Cancer Diagnostics Market Size, 2019-2021 (US$ Million)
Table 36. By Application, France Cancer Diagnostics Market Size, 2019-2021 (US$ Million)
Table 37. By Type, UK Cancer Diagnostics Market Size, 2019-2021 (US$ Million)
Table 38. By Application, UK Cancer Diagnostics Market Size, 2019-2021 (US$ Million)
Table 39. By Type, Italy Cancer Diagnostics Market Size, 2019-2021 (US$ Million)
Table 40. By Application, Italy Cancer Diagnostics Market Size, 2019-2021 (US$ Million)
Table 41. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 42. By Region, Asia-Pacific Cancer Diagnostics Market Size, 2019-2021 (US$ Million)
Table 43. By Type, China Cancer Diagnostics Market Size, 2019-2021 (US$ Million)
Table 44. By Application, China Cancer Diagnostics Market Size, 2019-2021 (US$ Million)
Table 45. By Type, Japan Cancer Diagnostics Market Size, 2019-2021 (US$ Million)
Table 46. By Application, Japan Cancer Diagnostics Market Size, 2019-2021 (US$ Million)
Table 47. By Type, South Korea Cancer Diagnostics Market Size, 2019-2021 (US$ Million)
Table 48. By Application, South Korea Cancer Diagnostics Market Size, 2019-2021 (US$ Million)
Table 49. By Type, India Cancer Diagnostics Market Size, 2019-2021 (US$ Million)
Table 50. By Application, India Cancer Diagnostics Market Size, 2019-2021 (US$ Million)
Table 51. By Type, ASEAN Cancer Diagnostics Market Size, 2019-2021 (US$ Million)
Table 52. By Application, ASEAN Cancer Diagnostics Market Size, 2019-2021 (US$ Million)
Table 53. By Type, Latin America Cancer Diagnostics Market Size, 2019-2021 (US$ Million)
Table 54. By Application, Latin America Cancer Diagnostics Market Size, 2019-2021 (US$ Million)
Table 55. By Type, Middle East and Africa Cancer Diagnostics Market Size, 2019-2021 (US$ Million)
Table 56. By Application, Middle East and Africa Cancer Diagnostics Market Size, 2019-2021 (US$ Million)
Table 57. Becton, Dickinson and Company Business Overview
Table 58. Becton, Dickinson and Company Cancer Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. Becton, Dickinson and Company Cancer Diagnostics Product
Table 60. Becton, Dickinson and Company Response to COVID-19 and Related Developments
Table 61. GE Healthcare Business Overview
Table 62. GE Healthcare Cancer Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. GE Healthcare Cancer Diagnostics Product
Table 64. GE Healthcare Response to COVID-19 and Related Developments
Table 65. Abbott Business Overview
Table 66. Abbott Cancer Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Abbott Cancer Diagnostics Product
Table 68. Abbott Response to COVID-19 and Related Developments
Table 69. Roche Business Overview
Table 70. Roche Cancer Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. Roche Cancer Diagnostics Product
Table 72. Roche Response to COVID-19 and Related Developments
Table 73. Thermo Fisher Scientific Business Overview
Table 74. Thermo Fisher Scientific Cancer Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Thermo Fisher Scientific Cancer Diagnostics Product
Table 76. Thermo Fisher Scientific Response to COVID-19 and Related Developments
Table 77. Agilent Technologies Business Overview
Table 78. Agilent Technologies Cancer Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. Agilent Technologies Cancer Diagnostics Product
Table 80. Agilent Technologies Response to COVID-19 and Related Developments
Table 81. Illumina Business Overview
Table 82. Illumina Cancer Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. Illumina Cancer Diagnostics Product
Table 84. Illumina Response to COVID-19 and Related Developments
Table 85. Siemens Healthcare Business Overview
Table 86. Siemens Healthcare Cancer Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. Siemens Healthcare Cancer Diagnostics Product
Table 88. Siemens Healthcare Response to COVID-19 and Related Developments
Table 89. C.R. Bard Business Overview
Table 90. C.R. Bard Cancer Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 91. C.R. Bard Cancer Diagnostics Product
Table 92. C.R. Bard Response to COVID-19 and Related Developments
List of Figures

Figure 1. Cancer Diagnostics Product Picture
Figure 2. Cancer Diagnostics Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Cancer Diagnostics Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Cancer Diagnostics Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Cancer Diagnostics Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Cancer Diagnostics Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Cancer Diagnostics Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Cancer Diagnostics Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Cancer Diagnostics Market Size Market Share, 2019-2021
  • Tosoh: Cancer Diagnostics Market Shares and Competitive Position by Product and Country--US, Europe, Japan--Performance, Capabilities, Goals and Strategies
    Published: 09-Jul-2020        Price: US 1250 Onwards        Pages: 0
    This unique market intelligence report from LeadingMarketResearch provides information not available from any other published source. The report includes cancer diagnostics sales and market share estimates by product and country for Tosoh and its main competitors, as well as a profile of the company's diagnostics business. ......
  • Roche: Cancer Diagnostics Market Shares and Competitive Position by Product and Country--US, Europe, Japan--Performance, Capabilities, Goals and Strategies
    Published: 08-Jul-2020        Price: US 1250 Onwards        Pages: 0
    This unique market intelligence report from LeadingMarketResearch provides information not available from any other published source. The report includes cancer diagnostics sales and market share estimates by product and country for Roche and its main competitors, as well as a profile of the company's diagnostics business. ......
  • Siemens Healthineers: Cancer Diagnostics Market Shares and Competitive Position by Product and Country--US, Europe, Japan--Performance, Capabilities, Goals and Strategies
    Published: 08-Jul-2020        Price: US 1350 Onwards        Pages: 0
    This unique market intelligence report from LeadingMarketResearch provides information not available from any other published source. The report includes cancer diagnostics sales and market share estimates by product and country for Siemens Healthineers and its main competitors, as well as a profile of the company's diagnostics business. ......
  • Global Solid Tumor Testing Market Size, Status and Forecast 2020-2026
    Published: 07-Jul-2020        Price: US 3900 Onwards        Pages: 98
    Solid Tumor Testing market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Solid Tumor Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026. The key players covered in this study - BD - Danaher - F. Hoffmann-La Roche -......
  • COVID-19 Outbreak-Global Oncology Molecular Diagnostics Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020
    Published: 07-Jul-2020        Price: US 3660 Onwards        Pages: 117
    The Oncology Molecular Diagnostics market revenue was xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025. Under COVID-19 outbreak globally, this report provides 360 degrees of analysis from supply chain, import and export control to regional government policy and future influence on the industry. Detailed analysis about market status (2015-2020), enterprise competition pattern, advantages and disadvantages of enterpris......
  • Abbott: Cancer Diagnostics Market Shares and Competitive Position by Product and Country--US, Europe, Japan--Performance, Capabilities, Goals and Strategies
    Published: 06-Jul-2020        Price: US 1450 Onwards        Pages: 0
    This unique market intelligence report from LeadingMarketResearch provides information not available from any other published source. The report includes cancer diagnostics sales and market share estimates by product and country for Abbott and its main competitors, as well as a profile of the company's diagnostics business. ......
  • Beckman Coulter: Cancer Diagnostics Market Shares and Competitive Position by Product and Country--US, Europe, Japan--Performance, Capabilities, Goals and Strategies
    Published: 06-Jul-2020        Price: US 1250 Onwards        Pages: 0
    This unique market intelligence report from LeadingMarketResearch provides information not available from any other published source. The report includes cancer diagnostics sales and market share estimates by product and country for Beckman Coulter and its main competitors, as well as a profile of the company's diagnostics business. ......
  • Global Pap Tests and HPV Tests Market Size, Status and Forecast 2020-2026
    Published: 03-Jul-2020        Price: US 3900 Onwards        Pages: 96
    Pap Tests and HPV Tests market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Pap Tests and HPV Tests market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026. The key players covered in this study - Abbott Laboratories - Arbor Vita Corporatio......
  • Emerging Cancer Diagnostic Markets: Innovative Technologies and Strategic Profiles of Leading Suppliers
    Published: 01-Jul-2020        Price: US 1500 Onwards        Pages: 110
    This report provides detailed assessments of such technologies as monoclonal antibodies, immunoassays, DNA probes, biochips/microarrays, chromosome analysis, IT, flow cytometry, biosensors, and their potential applications for cancer diagnostic testing. Also included is a review of competing/complementing technologies, such as CT, MRI, NMR, PET and photonics spectroscopy. Contains 110 pages......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs